Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Abbosh

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Plos Medicine|October 12, 2021
ctDNA: An emerging neoadjuvant biomarker in resectable solid tumorsChristopher Abbosh, Charles Swanton
Nature Reviews. Clinical Oncology|July 4, 2018
Early stage NSCLC - challenges to implementing ctDNA-based screening and MRD detectionChristopher Abbosh, Nicolai J Birkbak, Charles Swanton
Journal of Neurochemistry|February 2, 2011
GalR2/3 mediates proliferative and trophic effects of galanin on postnatal hippocampal precursorsChristopher Abbosh, Alexandra Lawkowski, Malik Zaben, et al.
Current Opinion in Systems Biology|January 4, 2019
Evolutionary dynamics in pre-invasive neoplasiaChristopher Abbosh, Subramanian Venkatesan, Samuel M Janes, et al.
Stem Cells (Dayton, Ohio)|August 4, 2009
The neurotransmitter VIP expands the pool of symmetrically dividing postnatal dentate gyrus precursors via VPAC2 receptors or directs them toward a neuronal fate via VPAC1 receptorsMalik Zaben, W John Sheward, Anan Shtaya, et al.
Cell Reports. Medicine|May 2, 2025
Low T cell diversity associates with poor outcome in bladder cancer: A comprehensive longitudinal analysis of the T cell receptor repertoireAsbjørn Kjær, Nanna Kristjánsdóttir, Randi Istrup Juul, et al.
Nature|March 19, 2026
Thymic health consequences in adultsSimon Bernatz, Vasco Prudente, Suraj Pai, et al.
CA: a Cancer Journal for Clinicians|February 6, 2019
Artificial intelligence in cancer imaging: Clinical challenges and applicationsWenya Linda Bi, Ahmed Hosny, Matthew B Schabath, et al.
Nature|March 19, 2026
Thymic health and immunotherapy outcomes in patients with cancerSimon Bernatz, Vasco Prudente, Suraj Pai, et al.
Science Translational Medicine|August 17, 2018
KHS101 disrupts energy metabolism in human glioblastoma cells and reduces tumor growth in miceEuan S Polson, Verena B Kuchler, Christopher Abbosh, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Plos Medicine|October 12, 2021
ctDNA: An emerging neoadjuvant biomarker in resectable solid tumorsChristopher Abbosh, Charles Swanton
Nature Reviews. Clinical Oncology|July 4, 2018
Early stage NSCLC - challenges to implementing ctDNA-based screening and MRD detectionChristopher Abbosh, Nicolai J Birkbak, Charles Swanton
Journal of Neurochemistry|February 2, 2011
GalR2/3 mediates proliferative and trophic effects of galanin on postnatal hippocampal precursorsChristopher Abbosh, Alexandra Lawkowski, Malik Zaben, et al.
Current Opinion in Systems Biology|January 4, 2019
Evolutionary dynamics in pre-invasive neoplasiaChristopher Abbosh, Subramanian Venkatesan, Samuel M Janes, et al.
Stem Cells (Dayton, Ohio)|August 4, 2009
The neurotransmitter VIP expands the pool of symmetrically dividing postnatal dentate gyrus precursors via VPAC2 receptors or directs them toward a neuronal fate via VPAC1 receptorsMalik Zaben, W John Sheward, Anan Shtaya, et al.
Cell Reports. Medicine|May 2, 2025
Low T cell diversity associates with poor outcome in bladder cancer: A comprehensive longitudinal analysis of the T cell receptor repertoireAsbjørn Kjær, Nanna Kristjánsdóttir, Randi Istrup Juul, et al.
Nature|March 19, 2026
Thymic health consequences in adultsSimon Bernatz, Vasco Prudente, Suraj Pai, et al.
CA: a Cancer Journal for Clinicians|February 6, 2019
Artificial intelligence in cancer imaging: Clinical challenges and applicationsWenya Linda Bi, Ahmed Hosny, Matthew B Schabath, et al.
Nature|March 19, 2026
Thymic health and immunotherapy outcomes in patients with cancerSimon Bernatz, Vasco Prudente, Suraj Pai, et al.
Science Translational Medicine|August 17, 2018
KHS101 disrupts energy metabolism in human glioblastoma cells and reduces tumor growth in miceEuan S Polson, Verena B Kuchler, Christopher Abbosh, et al.
Pageof 3